Scientists probe gene link to rare brain disease after infections
NCT ID NCT06731790
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how a specific gene mutation (RANBP2) affects the immune system in people with Acute Necrotizing Encephalopathy type 1 (ANE1), a rare brain condition triggered by infections. Researchers compared blood samples from 35 participants, including patients with the mutation and healthy controls, to measure inflammatory markers. The goal is to better understand why some people develop severe brain inflammation, which could guide future research into treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal why some people with a RANBP2 mutation develop severe brain inflammation after common infections, pointing toward future treatments.
- What could go wrong
- This is a small, early-stage study with only 35 participants, focused on understanding the disease rather than testing a treatment. Results may not apply to all patients or lead directly to therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE NECROTIZING ENCEPHALOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Gui de Chauliac
Montpellier, Hérault, 34295, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.